Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.

Del C Monroig-Bosque P, Driver B, Morales-Rosado JA, Deavers M, Tacha D, Bernicker E, Cagle PT, Miller RA.

Arch Pathol Lab Med. 2018 Nov;142(11):1388-1393. doi: 10.5858/arpa.2017-0516-OA. Epub 2018 Feb 12.

PMID:
29431467
2.

Do Skin Lacerations Imply Tissue Transfer From Surgeon to Patient During Arthroscopic Knot Tying?

Burn MB, Holtorf HL, Smith KM, Bernstein DT, Delgado DA, Prudhomme N, Deavers MT, McCulloch PC, Harris JD.

Arthroscopy. 2017 Dec;33(12):2248-2254. doi: 10.1016/j.arthro.2017.07.033. Epub 2017 Oct 21.

PMID:
29066268
3.

Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.

Driver BR, Miller RA, Miller T, Deavers M, Gorman B, Mody D, Ge Y, Barrios R, Bernicker E, Kim M, Cagle PT.

Arch Pathol Lab Med. 2017 Nov;141(11):1529-1532. doi: 10.5858/arpa.2017-0028-OA. Epub 2017 Aug 22.

PMID:
28829153
4.

Retiform Sertoli-Leydig Cell Tumor in a 38-Year-Old Woman: A Case Report, Retrospective Review, and Review of Current Literature.

Nwogu LC, Showalter JA, Roy S, Deavers MT, Zhao B.

Case Rep Pathol. 2017;2017:3421832. doi: 10.1155/2017/3421832. Epub 2017 Feb 20.

5.

Pannus of Mitral Valve Prosthesis Causing Left Ventricular Outflow Tract Obstruction.

Abudiab MM, McKay J, Deavers M, Zoghbi WA, Chang SM.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):183. No abstract available.

6.

The Utility of Core Needle Biopsy and Fine-Needle Aspiration in the Workup of Tumors of Suspected Müllerian Origin.

Crumley S, Okoye E, Deavers M, Coffey D.

Acta Cytol. 2015;59(6):465-73. doi: 10.1159/000443517. Epub 2016 Feb 11.

PMID:
26863309
7.

Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.

Driver BR, Portier BP, Mody DR, Deavers M, Bernicker EH, Kim MP, Teh BS, Santacruz JF, Kopas L, Munden RF, Cagle PT.

Arch Pathol Lab Med. 2016 Apr;140(4):312-7. doi: 10.5858/arpa.2015-0361-OA. Epub 2015 Oct 2.

PMID:
26430808
8.

Hidradenoma papilliferum associated with pregnancy: a case report.

McClain CM, Deavers MT, Sauls CD, Diwan AH.

J Cutan Pathol. 2015 Dec;42(12):983-986. doi: 10.1111/cup.12586. Epub 2015 Oct 13.

PMID:
26265265
9.

Collision of Ductal Carcinoma In Situ of Anogenital Mammary-like Glands and Vulvar Sarcomatoid Squamous Cell Carcinoma.

Tran TA, Deavers MT, Carlson JA, Malpica A.

Int J Gynecol Pathol. 2015 Sep;34(5):487-94. doi: 10.1097/PGP.0000000000000184.

PMID:
26107561
10.

Concurrent primary peritoneal low-grade serous carcinoma and endometrial high-grade serous carcinoma.

Lockyer MG, Deavers MT, Zarrin-Khameh N.

Int J Gynecol Pathol. 2015 May;34(3):288-92. doi: 10.1097/PGP.0000000000000133.

11.

Pulmonary artery intimal sarcoma diagnosed using endobronchial ultrasound-guided transbronchial needle aspiration.

Caraway NP, Salina D, Deavers MT, Morice R, Landon G.

Cytojournal. 2015 Feb 18;12:3. doi: 10.4103/1742-6413.151667. eCollection 2015.

12.

GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.

Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT.

Histopathology. 2015 Aug;67(2):245-54. doi: 10.1111/his.12645. Epub 2015 Feb 23.

PMID:
25564996
13.

Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.

Li W, Liang Y, Deavers MT, Kamat AM, Matin SF, Dinney CP, Czerniak B, Guo CC.

Am J Clin Pathol. 2014 Dec;142(6):864-71. doi: 10.1309/AJCP1J0JPJBPSUXF.

PMID:
25389341
14.

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.

Tsang YT, Deavers MT, Sun CC, Kwan SY, Kuo E, Malpica A, Mok SC, Gershenson DM, Wong KK.

J Pathol. 2013 Dec;231(4):449-56. doi: 10.1002/path.4252.

15.

Spontaneous hip dislocation secondary to intraarticular neurofibroma: a case report.

Kumar R, dos Reis Teixeira Neto A, Deavers MT, Amini B, Lewis VO.

Skeletal Radiol. 2014 Jul;43(7):1007-11. doi: 10.1007/s00256-014-1828-3. Epub 2014 Feb 4.

PMID:
24492891
16.

Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.

Huang J, Hu W, Bottsford-Miller J, Liu T, Han HD, Zand B, Pradeep S, Roh JW, Thanapprapasr D, Dalton HJ, Pecot CV, Rupaimoole R, Lu C, Fellman B, Urbauer D, Kang Y, Jennings NB, Huang L, Deavers MT, Broaddus R, Coleman RL, Sood AK.

Clin Cancer Res. 2014 Apr 1;20(7):1846-55. doi: 10.1158/1078-0432.CCR-13-2141. Epub 2014 Jan 31.

17.

Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?

Kawaguchi S, Sun T, Lin PP, Deavers M, Harun N, Lewis VO.

Clin Orthop Relat Res. 2014 Mar;472(3):983-9. doi: 10.1007/s11999-013-3360-5. Epub 2013 Nov 7.

18.

Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases.

Masand RP, Euscher ED, Deavers MT, Malpica A.

Am J Surg Pathol. 2013 Nov;37(11):1635-47. doi: 10.1097/PAS.0000000000000083.

PMID:
24121169
19.

ERG and FLI1 protein expression in epithelioid sarcoma.

Stockman DL, Hornick JL, Deavers MT, Lev DC, Lazar AJ, Wang WL.

Mod Pathol. 2014 Apr;27(4):496-501. doi: 10.1038/modpathol.2013.161. Epub 2013 Sep 27.

20.

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.

Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, Fritsche H, Bast RC Jr.

Cancer. 2013 Oct 1;119(19):3454-61. doi: 10.1002/cncr.28183. Epub 2013 Aug 26.

21.

Poor survival with wild-type TP53 ovarian cancer?

Wong KK, Izaguirre DI, Kwan SY, King ER, Deavers MT, Sood AK, Mok SC, Gershenson DM.

Gynecol Oncol. 2013 Sep;130(3):565-9. doi: 10.1016/j.ygyno.2013.06.016. Epub 2013 Jun 22.

22.

Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix.

Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH.

Gynecol Oncol. 2013 Dec;131(3):645-9. doi: 10.1016/j.ygyno.2013.04.056. Epub 2013 Apr 30.

PMID:
23643871
23.

Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern.

Estrella JS, Wolf JK, Deavers MT.

Arch Pathol Lab Med. 2013 Feb;137(2):275-9. doi: 10.5858/arpa.2011-0200-CR.

PMID:
23368871
24.

Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, Soman KV, Shahzad MM, Zigler M, Deavers MT, Zien A, Soldatos TG, Jackson DB, Wiktorowicz JE, Torres-Lugo M, Young T, De Geest K, Gallick GE, Bar-Eli M, Lopez-Berestein G, Cole SW, Lopez GE, Lutgendorf SK, Sood AK.

Nat Commun. 2013;4:1403. doi: 10.1038/ncomms2413. Erratum in: Nat Commun. 2013;4:1932. Shazhad, Mian M K [corrected to Shahzad, Mian M K].

25.

Posttraumatic intramedullary osteochondroma: report of a case.

Kumar R, Deavers MT, Dos Reis Teixeira Neto A, Moon BS, Madewell JE.

Skeletal Radiol. 2013 May;42(5):725-8. doi: 10.1007/s00256-012-1564-5. Epub 2013 Jan 27.

PMID:
23354526
26.

Low-grade smooth muscle tumors of the primary and the secondary mullerian system: a proposed concept of multicentricity.

Posligua L, Silva EG, Deavers MT, Merino MJ, Malpica A.

Int J Gynecol Pathol. 2012 Nov;31(6):547-55. doi: 10.1097/PGP.0b013e31824d3539.

PMID:
23018207
27.

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.

Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT.

Histopathology. 2013 Jan;62(2):267-74. doi: 10.1111/j.1365-2559.2012.04344.x. Epub 2012 Sep 11.

28.

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK.

Gynecol Oncol. 2012 Dec;127(3):538-43. doi: 10.1016/j.ygyno.2012.08.020. Epub 2012 Aug 23. Erratum in: Gynecol Oncol. 2013 Jul;130(1):252-3.

29.

"Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer.

Frumovitz M, Euscher ED, Deavers MT, Soliman PT, Schmeler KM, Ramirez PT, Levenback CF.

Gynecol Oncol. 2012 Dec;127(3):467-71. doi: 10.1016/j.ygyno.2012.08.015. Epub 2012 Aug 19.

30.

The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer.

Li X, Deavers MT, Guo M, Liu P, Gong Y, Albarracin CT, Middleton LP, Huo L.

Mod Pathol. 2013 Jan;26(1):71-8. doi: 10.1038/modpathol.2012.135. Epub 2012 Aug 17.

31.

Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix with ovarian metastasis of the former component: a report of 2 cases.

Ramalingam P, Malpica A, Deavers MT.

Int J Gynecol Pathol. 2012 Sep;31(5):490-6. doi: 10.1097/PGP.0b013e31824735a5.

PMID:
22833092
32.

Melan A (A103) is not a marker of mesothelioma.

Ordóñez NG, Shen SS, Zenali M, Deavers MT.

Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):181-4. doi: 10.1097/PAI.0b013e31825e0013.

PMID:
22820661
33.

Enchondroma with secondary aneurysmal bone cyst.

Bird JE, Wang WL, Deavers MT, Madewell J, Lewis VO.

Skeletal Radiol. 2012 Nov;41(11):1475-8. Epub 2012 May 26.

PMID:
22639202
34.

The natural history of primary temporal bone myxoma.

Guha-Thakurta N, Deavers M, DeMonte F, Gidley PW.

Ann Diagn Pathol. 2012 Aug;16(4):280-3. doi: 10.1016/j.anndiagpath.2011.12.001. Epub 2012 Apr 5.

PMID:
22483549
35.

Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.

Landon G, Stewart J, Deavers M, Lu K, Sneige N.

Gynecol Oncol. 2012 Jun;125(3):683-6. doi: 10.1016/j.ygyno.2012.03.009. Epub 2012 Mar 13.

36.

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.

Gershenson DM, Sun CC, Iyer RB, Malpica AL, Kavanagh JJ, Bodurka DC, Schmeler K, Deavers M.

Gynecol Oncol. 2012 Jun;125(3):661-6. doi: 10.1016/j.ygyno.2012.02.037. Epub 2012 Mar 6.

37.

Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.

Engler DA, Gupta S, Growdon WB, Drapkin RI, Nitta M, Sergent PA, Allred SF, Gross J, Deavers MT, Kuo WL, Karlan BY, Rueda BR, Orsulic S, Gershenson DM, Birrer MJ, Gray JW, Mohapatra G.

PLoS One. 2012;7(2):e30996. doi: 10.1371/journal.pone.0030996. Epub 2012 Feb 15.

38.

Paraneoplastic thrombocytosis in ovarian cancer.

Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond VK, Wang R, Drew AF, Gushiken F, Lamkin D, Collins K, DeGeest K, Lutgendorf SK, Chiu W, Lopez-Berestein G, Afshar-Kharghan V, Sood AK.

N Engl J Med. 2012 Feb 16;366(7):610-8. doi: 10.1056/NEJMoa1110352. Erratum in: N Engl J Med. 2012 Nov;367(18):1768. Lamkin, Donald [added].

39.

Chondroid melanoma metastatic to lung and skin showing SOX-9 expression: a potential diagnostic pitfall.

McKay KM, Deavers MT, Prieto VG.

Int J Surg Pathol. 2012 Apr;20(2):169-72. doi: 10.1177/1066896911436275. Epub 2012 Feb 13.

PMID:
22334614
40.

Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix.

Costales AB, Eifel PJ, Deavers MT, Frumovitz M, Schmeler KM.

Gynecol Oncol Case Rep. 2012 May 9;2(3):97-9. doi: 10.1016/j.gynor.2012.05.001. eCollection 2012.

41.

A novel platform for detection of CK+ and CK- CTCs.

Pecot CV, Bischoff FZ, Mayer JA, Wong KL, Pham T, Bottsford-Miller J, Stone RL, Lin YG, Jaladurgam P, Roh JW, Goodman BW, Merritt WM, Pircher TJ, Mikolajczyk SD, Nick AM, Celestino J, Eng C, Ellis LM, Deavers MT, Sood AK.

Cancer Discov. 2011 Dec;1(7):580-6. doi: 10.1158/2159-8290.CD-11-0215. Epub 2011 Nov 3.

42.

The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer.

Huang L, Schauer IG, Zhang J, Mercado-Uribe I, Deavers MT, Huang J, Liu J.

Int J Clin Exp Pathol. 2011;4(7):644-50. Epub 2011 Sep 15.

43.

Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.

Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson RE, Steinhoff M, Behmaram B, Rasty G, Gershenson DM.

Cancer. 2012 Jun 15;118(12):3087-94. doi: 10.1002/cncr.26618. Epub 2011 Nov 9.

44.

Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.

Malpica A, Sant'Ambrogio S, Deavers MT, Silva EG.

Am J Surg Pathol. 2012 Jan;36(1):117-27. doi: 10.1097/PAS.0b013e3182354a79.

PMID:
22024662
45.

Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.

Malpica A, Deavers MT.

Int J Gynecol Pathol. 2011 Nov;30(6):613-9. doi: 10.1097/PGP.0b013e318217137e.

PMID:
21979600
46.

Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.

Nick AM, Stone RL, Armaiz-Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P, Bottsford-Miller J, Kim HS, Lee JS, Kim SM, Baggerly KA, Ram PT, Deavers MT, Coleman RL, Lopez-Berestein G, Sood AK.

J Natl Cancer Inst. 2011 Nov 2;103(21):1596-612. doi: 10.1093/jnci/djr372. Epub 2011 Sep 28.

47.

Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.

Hu W, Lu C, Dong HH, Huang J, Shen DY, Stone RL, Nick AM, Shahzad MM, Mora E, Jennings NB, Lee SJ, Roh JW, Matsuo K, Nishimura M, Goodman BW, Jaffe RB, Langley RR, Deavers MT, Lopez-Berestein G, Coleman RL, Sood AK.

Cancer Res. 2011 Sep 15;71(18):6030-9. doi: 10.1158/0008-5472.CAN-10-2719. Epub 2011 Jul 27.

48.

Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall.

McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG.

J Cutan Pathol. 2011 Oct;38(10):818-22. doi: 10.1111/j.1600-0560.2011.01743.x. Epub 2011 Jul 14.

PMID:
21752053
49.

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.

King ER, Zu Z, Tsang YT, Deavers MT, Malpica A, Mok SC, Gershenson DM, Wong KK.

Gynecol Oncol. 2011 Oct;123(1):13-8. doi: 10.1016/j.ygyno.2011.06.016. Epub 2011 Jul 2.

50.

Intraneural parachordoma of the arm with regional metastases.

De Comas AM, Deavers MT, Raymond AK, Madewell JE, Lewis VO.

Skeletal Radiol. 2011 Jul;40(7):943-6. doi: 10.1007/s00256-011-1151-1. Epub 2011 Apr 18.

PMID:
21499979

Supplemental Content

Loading ...
Support Center